ArticleFrontiers in immunology2025
Identification and characterization of senescent macrophages in renal allograft rejection: a cross-species MultiOmics study.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Allograft rejection remains a main hindrance for long-term graft survival. Cellular senescence (CS) contributes to graft injury, but the role of immune cell senescence in rejection remains unclear. Methods: Microarray data from renal transplant biopsy cohorts and age-matched rat allograft models were integrated to characterize senescence phenotypes. Immune cell infiltration algorithms and histopathology were employed to recognize major senescent alloimmune subpopulation. Then, novel senescent infiltrating macrophages (SnIMs) were identified using cross-species single-cell transcriptomics and validated in rat models. Finally, the clinical values of SnIMs were evaluated in renal transplant datasets. Results: CS gene sets were enriched in rejecting allografts, correlating with graft loss and pathological injury. Alloimmune responses amplified stress-induced senescence in rat allografts, with p21+ macrophages emerging as the important senescent immune subtype. SnIMs exhibited cell cycle arrest, upregulation of senescence-associated secretory phenotype, and conserved transcriptional signatures driven by NF-κB/Cebpb across species through single-cell analysis. These cells accumulated along pseudotime during rejection and interacted with effector T cells via CXCL chemokines. Clinically, SnIM infiltration predicted T cell-mediated rejection and correlated with Banff lesion grades and poor graft survival. Conclusions: Our findings identify novel stress-induced SnIMs in renal allograft rejection and highlight their pathogenic role in rejection injury, providing a therapeutic target to improve renal transplant outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.